Optimize The Formulation Of A Monoclonal Antibody

You have a molecule of interest and need an effective formulation to maximize stability and minimize aggregation. As with all formulations, it is essential that the buffers and excipients ensure stability of the drug substance, be compatible with each other and meet regulatory requirements. An emerging biotech company sought our help in developing a formulation for a monoclonal antibody.  Learn how we have delivered an optimized formulation for this customer in three months.

Learn more from LS Process Validation Expert, Nadia Oueslati, Ph.D. from BioReliance® End-to-End Solutions, MilliporeSigma.